Knockout controls and the specificity of cannabinoid CB2 receptor antibodies

被引：8
|
作者：
Ashton, John C. [1 ]
机构：
[1] Univ Otago, Dept Pharmacol & Toxicol, Otago Sch Med Sci, Dunedin 9054, New Zealand
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2011年 / 163卷 / 06期
关键词：
RAT CEREBELLUM; EXPRESSION;
D O I：
10.1111/j.1476-5381.2010.01139.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1113 / 1113
页数：1
相关论文
共 50 条
  • [1] Knockout controls and the specificity of cannabinoid CB2 receptor antibodies Reply
    Atwood, Brady
    Mackie, Ken
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1114 - 1114
  • [2] Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity
    Marchalant, Yannick
    Brownjohn, Philip W.
    Bonnet, Amandine
    Kleffmann, Torsten
    Ashton, John C.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (06) : 395 - 404
  • [3] The CB2 cannabinoid receptor controls myeloid progenitor trafficking
    Palazuelos, Javier
    Davoust, Nathalie
    Julien, Boris
    Hatterer, Eric
    Aguado, Tania
    Mechoulam, Raphael
    Benito, Cristina
    Romero, Julian
    Silva, Augusto
    Guzman, Manuel
    Nataf, Serge
    Galve-Roperh, Ismael
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) : 13320 - 13329
  • [4] CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies
    Zhang, Hai-ying
    Shen, Hui
    Jordan, Chloe J.
    Liu, Qing-rong
    Gardner, Eliot L.
    Bonci, Antonello
    Xi, Zheng-xiong
    [J]. ACTA PHARMACOLOGICA SINICA, 2019, 40 (03) : 398 - 409
  • [5] CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies
    Hai-ying Zhang
    Hui Shen
    Chloe J. Jordan
    Qing-rong Liu
    Eliot L. Gardner
    Antonello Bonci
    Zheng-xiong Xi
    [J]. Acta Pharmacologica Sinica, 2019, 40 : 398 - 409
  • [6] Cannabinoid Receptor CB2 Structure and CB2/Gi Signaling Mechanisms
    Xing, Changrui
    Zhang, Cheng
    Xie, Xiang-Qun
    [J]. FASEB JOURNAL, 2019, 33
  • [7] Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective Agonists
    Ashton, John C.
    Wright, Jason L.
    McPartland, John M.
    Tyndall, Joel D. A.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (14) : 1428 - 1443
  • [8] CB2: a cannabinoid receptor with an identity crisis
    Atwood, Brady K.
    Mackie, Ken
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 467 - 479
  • [9] Brain Cannabinoid CB2 Receptor in Schizophrenia
    Ishiguro, Hiroki
    Horiuchi, Yasue
    Ishikawa, Maya
    Koga, Minori
    Imai, Keiko
    Suzuki, Yoshimi
    Morikawa, Miyuki
    Inada, Toshiya
    Watanabe, Yuichiro
    Takahashi, Makoto
    Someya, Toshiyuki
    Ujike, Hiroshi
    Iwata, Nakao
    Ozaki, Norio
    Onaivi, Emmanuel S.
    Kunugi, Hiroshi
    Sasaki, Tsukasa
    Itokawa, Masanari
    Arai, Makoto
    Niizato, Kazuhiro
    Iritani, Shyuji
    Naka, Izumi
    Ohashi, Jun
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Nawa, Hiroyuki
    Arinami, Tadao
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 974 - 982
  • [10] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    [J]. PAIN, 2006, 122 (1-2) : 36 - 42
12345